Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Sucralfate Tablets USP,1 g Ratiopharm GmbH & Co. Arzneimittel ANDA 74-415 SUCRALFATE Suspension; 1GM/10ML CARAFATE AVENTIS 018333 SUCRALFATE Tablet; 1GM CARAFATE BLUE RIDGE 074415 SUCRALFATE Tablet; 1GM SUCRALFATE RATIOPHARM 070848 SUCRALFATE Tablet; 1GM SUCRALFATE Teva | Carafate (sucralfate) Suspension, Axcan Scandipharm, Package Change | Carafate (sucralfate) Suspension, Axcan Scandipharm, Labeling Revision | Carafate (sucralfate) Tablets, Axcan Scandipharm, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com